Concepedia

Publication | Open Access

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

DOIFull Paper Access

5.4K

Citations

95

References

2010

Year

Philip W. Kantoff, Celestia S. Higano, Neal D. Shore, E. Roy Berger, Eric J. Small, David F. Penson, Charles H. Redfern, Anna C. Ferrari, Robert Dreicer, Robert B. Sims,
New England Journal of Medicine

Abstract

The use of sipuleucel-T prolonged overall survival among men with metastatic castration-resistant prostate cancer. No effect on the time to disease progression was observed. (Funded by Dendreon; ClinicalTrials.gov number, NCT00065442.)

References

YearCitations

Page 1